Search

Jean F. Voltaire

Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )

Most Active Art Unit
2466
Art Unit(s)
2466, 2417
Total Applications
487
Issued Applications
381
Pending Applications
55
Abandoned Applications
68

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7234588 [patent_doc_number] => 20050256208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Pharmaceutical composition containing bakuchiol for treating woman breast cancer' [patent_app_type] => utility [patent_app_number] => 11/126225 [patent_app_country] => US [patent_app_date] => 2005-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3926 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256208.pdf [firstpage_image] =>[orig_patent_app_number] => 11126225 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/126225
Pharmaceutical composition containing bakuchiol for treating woman breast cancer May 10, 2005 Abandoned
Array ( [id] => 5085883 [patent_doc_number] => 20070275934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments' [patent_app_type] => utility [patent_app_number] => 11/596330 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14896 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275934.pdf [firstpage_image] =>[orig_patent_app_number] => 11596330 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/596330
Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments May 9, 2005 Abandoned
Array ( [id] => 5005537 [patent_doc_number] => 20070203109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Compounds And Compositions For Treatment Of Cancer' [patent_app_type] => utility [patent_app_number] => 11/568633 [patent_app_country] => US [patent_app_date] => 2005-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8012 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203109.pdf [firstpage_image] =>[orig_patent_app_number] => 11568633 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/568633
Compounds And Compositions For Treatment Of Cancer May 5, 2005 Abandoned
Array ( [id] => 7224506 [patent_doc_number] => 20050261260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Combination of a CDK inhibitor and mitoxantrone' [patent_app_type] => utility [patent_app_number] => 11/124636 [patent_app_country] => US [patent_app_date] => 2005-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6342 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261260.pdf [firstpage_image] =>[orig_patent_app_number] => 11124636 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/124636
Combination of a CDK inhibitor and mitoxantrone May 4, 2005 Abandoned
Array ( [id] => 7055692 [patent_doc_number] => 20050276866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Combination comprising a CDK inhibitor and cisplatin' [patent_app_type] => utility [patent_app_number] => 11/121753 [patent_app_country] => US [patent_app_date] => 2005-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5699 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20050276866.pdf [firstpage_image] =>[orig_patent_app_number] => 11121753 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/121753
Combination comprising a CDK inhibitor and cisplatin May 2, 2005 Abandoned
Array ( [id] => 7051384 [patent_doc_number] => 20050187271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid and/or its physiologically tolerable salts as a cancer-fighting agent' [patent_app_type] => utility [patent_app_number] => 11/117569 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2422 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187271.pdf [firstpage_image] =>[orig_patent_app_number] => 11117569 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/117569
Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid and/or its physiologically tolerable salts as a cancer-fighting agent Apr 28, 2005 Abandoned
Array ( [id] => 7051297 [patent_doc_number] => 20050187184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Antineoplastic combinations' [patent_app_type] => utility [patent_app_number] => 11/110050 [patent_app_country] => US [patent_app_date] => 2005-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4694 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187184.pdf [firstpage_image] =>[orig_patent_app_number] => 11110050 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/110050
Antineoplastic combinations Apr 19, 2005 Abandoned
Array ( [id] => 5189219 [patent_doc_number] => 20070167528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Methods of treating hepatocellular carcinoma with denspm' [patent_app_type] => utility [patent_app_number] => 11/548000 [patent_app_country] => US [patent_app_date] => 2005-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3195 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167528.pdf [firstpage_image] =>[orig_patent_app_number] => 11548000 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/548000
Methods of treating hepatocellular carcinoma with denspm Apr 11, 2005 Abandoned
Array ( [id] => 5199784 [patent_doc_number] => 20070299102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 10/599121 [patent_app_country] => US [patent_app_date] => 2005-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 26904 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20070299102.pdf [firstpage_image] =>[orig_patent_app_number] => 10599121 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/599121
Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer Apr 7, 2005 Abandoned
Array ( [id] => 5211055 [patent_doc_number] => 20070249639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Use of 9H-Purine-2,6-Diamine Derivatives in the Treatment of Proliferative Diseases and Novel 9H-Purine-2,6-Diamine Derivatives' [patent_app_type] => utility [patent_app_number] => 10/594412 [patent_app_country] => US [patent_app_date] => 2005-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18572 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249639.pdf [firstpage_image] =>[orig_patent_app_number] => 10594412 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/594412
Use of 9H-Purine-2,6-Diamine Derivatives in the Treatment of Proliferative Diseases and Novel 9H-Purine-2,6-Diamine Derivatives Apr 3, 2005 Abandoned
Array ( [id] => 5786760 [patent_doc_number] => 20060205757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => '39-desmethoxyrapamycin, compositions and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/097605 [patent_app_country] => US [patent_app_date] => 2005-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13090 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205757.pdf [firstpage_image] =>[orig_patent_app_number] => 11097605 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/097605
39-desmethoxyrapamycin, compositions and methods of use thereof Mar 31, 2005 Issued
Array ( [id] => 6959626 [patent_doc_number] => 20050215593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Methods treating tumors with thalidomide' [patent_app_type] => utility [patent_app_number] => 11/096155 [patent_app_country] => US [patent_app_date] => 2005-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6316 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215593.pdf [firstpage_image] =>[orig_patent_app_number] => 11096155 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/096155
Methods for inhibiting undesired angiogenesis in patients having tumors with thalidomide Mar 30, 2005 Issued
Array ( [id] => 7020230 [patent_doc_number] => 20050222249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Softgel of NLKJ for treating prostate diseases' [patent_app_type] => utility [patent_app_number] => 11/099780 [patent_app_country] => US [patent_app_date] => 2005-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1638 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222249.pdf [firstpage_image] =>[orig_patent_app_number] => 11099780 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/099780
Softgel of NLKJ for treating prostate diseases Mar 27, 2005 Issued
Array ( [id] => 7020230 [patent_doc_number] => 20050222249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Softgel of NLKJ for treating prostate diseases' [patent_app_type] => utility [patent_app_number] => 11/099780 [patent_app_country] => US [patent_app_date] => 2005-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1638 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222249.pdf [firstpage_image] =>[orig_patent_app_number] => 11099780 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/099780
Softgel of NLKJ for treating prostate diseases Mar 27, 2005 Issued
Array ( [id] => 4887682 [patent_doc_number] => 20080262014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Use of Camptothecin Derivatives for the Treatment of Proliferative Diseases in a Fixed Dosing Regimen' [patent_app_type] => utility [patent_app_number] => 10/592832 [patent_app_country] => US [patent_app_date] => 2005-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2118 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262014.pdf [firstpage_image] =>[orig_patent_app_number] => 10592832 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/592832
Use of Camptothecin Derivatives for the Treatment of Proliferative Diseases in a Fixed Dosing Regimen Mar 23, 2005 Abandoned
Array ( [id] => 4740651 [patent_doc_number] => 20080234304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'N3-Pyridyl-Thiamine And Its Use In Cancer Treatments' [patent_app_type] => utility [patent_app_number] => 10/594191 [patent_app_country] => US [patent_app_date] => 2005-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 7068 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234304.pdf [firstpage_image] =>[orig_patent_app_number] => 10594191 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/594191
N3-Pyridyl-Thiamine And Its Use In Cancer Treatments Mar 22, 2005 Abandoned
Array ( [id] => 4846458 [patent_doc_number] => 20080182866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Tetra-Cyclic Carboline Derivatives Useful in the Inhibition of Angiogenesis' [patent_app_type] => utility [patent_app_number] => 10/592761 [patent_app_country] => US [patent_app_date] => 2005-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11998 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182866.pdf [firstpage_image] =>[orig_patent_app_number] => 10592761 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/592761
Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis Mar 14, 2005 Issued
Array ( [id] => 4613312 [patent_doc_number] => 07989468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Methods of using SNS-595' [patent_app_type] => utility [patent_app_number] => 11/080283 [patent_app_country] => US [patent_app_date] => 2005-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4003 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/989/07989468.pdf [firstpage_image] =>[orig_patent_app_number] => 11080283 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/080283
Methods of using SNS-595 Mar 13, 2005 Issued
Array ( [id] => 4432249 [patent_doc_number] => 07968565 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Therapeutic combinations comprising (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid' [patent_app_type] => utility [patent_app_number] => 11/080102 [patent_app_country] => US [patent_app_date] => 2005-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7370 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968565.pdf [firstpage_image] =>[orig_patent_app_number] => 11080102 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/080102
Therapeutic combinations comprising (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid Mar 13, 2005 Issued
Array ( [id] => 7250786 [patent_doc_number] => 20050272758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Antineoplastic combinations of CCI-779 and rituximab' [patent_app_type] => utility [patent_app_number] => 11/075509 [patent_app_country] => US [patent_app_date] => 2005-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2754 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272758.pdf [firstpage_image] =>[orig_patent_app_number] => 11075509 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/075509
Antineoplastic combinations of CCI-779 and rituximab Mar 8, 2005 Abandoned
Menu